Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Midday Highlights on July 14

Midday Highlights on July 14

金色财经金色财经2026/07/14 04:02
Show original
7:00-12:00 Keywords: Ethereum, Uniswap, Clarity Act1. Federal Reserve Spokesperson: Core CPI is more important to the Federal Reserve;2. U.S. military: Completed a new round of strikes against Iraq, with 50 thousand soldiers deployed in the Middle East;3. Ethereum co-founder: Ethereum L1 revenues and fees should be kept low to promote growth;4. Uniswap bought back and burned 38 thousand UNI yesterday, accounting for only about 2.5% of total protocol fees;5. A certain exchange: Bitcoin remains relatively resilient amid multiple negatives, which may indicate the market is forming a bottom;6. The U.S. Association of Federal Law Enforcement Officers supports the "Clarity Act," but calls for enhanced DeFi accountability provisions;7. The U.S. government deposited 3,940 BTC and 30,006 ETH into a certain exchange, worth $297 million;8. U.S. Senator: Only Congress can grant CFTC authority to regulate spot digital assets, and the "Clarity Act" is the only feasible approach.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Saving in the US, paying globally? Industry research warns: Trump’s push to lower drug prices could instead incentivize pharmaceutical companies to raise prices overseas

A study published in The Lancet indicates that Trump's efforts to lower drug prices in the United States may force pharmaceutical companies to raise prices internationally or exit certain markets, potentially leading to a significant reduction in the approximately $11.6 billion saved annually by Medicare.

智通财经2026/09/14 00:46
Saving in the US, paying globally? Industry research warns: Trump’s push to lower drug prices could instead incentivize pharmaceutical companies to raise prices overseas